|
|
||||||||

* Emory Vaccine Center and Department of Pathology, Atlanta, GA 30329; and
Division of Basic and Clinical Immunology, University of California, Irvine, CA 92697-4096
Activation of MAPK ERK1/2 has been shown to play an important role in Th1/Th2 polarization and in regulating cytokine production from APCs. The ERK family consists of two members ERK1 and ERK2, which share
84% identity at the amino acid level and can compensate for each other for most functions. Despite these features, ERK1 and ERK2 do serve different functions, but there is very little information on the contribution of individual forms of ERK on innate and adaptive immune responses. In this study, we describe that ERK1/ mice display a bias toward Th1 type immune response. Consistent with this observation, dendritic cells from ERK1/ mice show enhanced IL-12p70 and reduced IL-10 secretion in response to TLR stimulation. Furthermore, serum from ERK1/ mice had 100-fold higher total IgG2b and 10-fold higher total IgG2a and IgG1 Ab isotype titers, and enhanced levels of Ag-specific IgG2b Ab titers, compared with wild-type mice. Consistent with this enhanced Th1 bias, ERK1/ mice showed enhanced susceptibility to myelin oligodendrocyte glycoprotein (MOG)3555 peptide-induced experimental autoimmune encephalomyelitis (EAE) and developed EAE earlier, and with increased severity, compared with wild-type mice. Importantly, there was a profound skewing toward Th1 responses in ERK1/ mice, with higher IFN-
production and lower IL-5 production in MOG3555-primed T cells, as well as an augmentation in the MOG-specific IgG2a and IgG2b Th1 Ab isotypes. Finally, increased infiltrating cells and myelin destruction was observed in the spinal cord of ERK1/ mice. Taken together, our data suggest that deficiency of ERK1 biases the immune response toward Th1 resulting in increased susceptibility to EAE.
This article has been cited by other articles:
![]() |
D. C. Wraith, R. Pope, H. Butzkueven, H. Holder, P. Vanderplank, P. Lowrey, M. J. Day, A. L. Gundlach, T. J. Kilpatrick, N. Scolding, et al. A role for galanin in human and experimental inflammatory demyelination PNAS, September 8, 2009; 106(36): 15466 - 15471. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. F. Brereton, C. E. Sutton, S. J. Lalor, E. C. Lavelle, and K. H. G. Mills Inhibition of ERK MAPK Suppresses IL-23- and IL-1-Driven IL-17 Production and Attenuates Autoimmune Disease J. Immunol., August 1, 2009; 183(3): 1715 - 1723. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. N. D'Souza, C.-F. Chang, A. M. Fischer, M. Li, and S. M. Hedrick The Erk2 MAPK Regulates CD8 T Cell Proliferation and Survival J. Immunol., December 1, 2008; 181(11): 7617 - 7629. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Reijerkerk, G. Kooij, S. M. A. van der Pol, T. Leyen, B. van het Hof, P.-O. Couraud, D. Vivien, C. D. Dijkstra, and H. E. de Vries Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier J. Immunol., September 1, 2008; 181(5): 3567 - 3574. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shiraishi, H. Yoshida, K. Saeki, Y. Miura, S. Watanabe, T. Ishizaki, M. Hashimoto, G. Takaesu, T. Kobayashi, and A. Yoshimura Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells Int. Immunol., September 1, 2008; 20(9): 1219 - 1229. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. R. Kroening, T. W. Barnes, L. Pease, A. Limper, H. Kita, and R. Vassallo Cigarette Smoke-Induced Oxidative Stress Suppresses Generation of Dendritic Cell IL-12 and IL-23 through ERK-Dependent Pathways J. Immunol., July 15, 2008; 181(2): 1536 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Liang, C. Workman, J. Lee, C. Chew, B. M. Dale, L. Colonna, M. Flores, N. Li, E. Schweighoffer, S. Greenberg, et al. Regulatory T Cells Inhibit Dendritic Cells by Lymphocyte Activation Gene-3 Engagement of MHC Class II J. Immunol., May 1, 2008; 180(9): 5916 - 5926. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Escors, L. Lopes, R. Lin, J. Hiscott, S. Akira, R. J. Davis, and M. K. Collins Targeting dendritic cell signaling to regulate the response to immunization Blood, March 15, 2008; 111(6): 3050 - 3061. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Lefloch, J. Pouyssegur, and P. Lenormand Single and Combined Silencing of ERK1 and ERK2 Reveals Their Positive Contribution to Growth Signaling Depending on Their Expression Levels Mol. Cell. Biol., January 1, 2008; 28(1): 511 - 527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Schnitzler, J. M. Burke, and L. M. Wetzler Induction of Cell Signaling Events by the Cholera Toxin B Subunit in Antigen-Presenting Cells Infect. Immun., June 1, 2007; 75(6): 3150 - 3159. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Shin, Y. H. Kim, B. K. Choi, P. M. Kwon, H.-W. Lee, and B. S. Kwon 4-1BB triggers IL-13 production from T cells to limit the polarized, Th1-mediated inflammation J. Leukoc. Biol., June 1, 2007; 81(6): 1455 - 1465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |